Mona S Abdellateif
Overview
Explore the profile of Mona S Abdellateif including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
223
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mohanad M, Hamza H, Bahnassy A, Shaarawy S, Ahmed O, El-Mezayen H, et al.
Sci Rep
. 2025 Feb;
15(1):6894.
PMID: 40011499
Epigenetic alterations, especially promotor methylation, have a significant impact on gene expression, molecular subtyping, prognosis, and outcome of breast cancer (BC). The methylation profile was assessed for 22 genes of...
2.
Abdel-Hamid R, Bayoumi A, Abdellateif M, Nooh H, Refaat L, Kandeel E, et al.
J Infect Dev Ctries
. 2024 Sep;
18(8):1185-1195.
PMID: 39288390
Introduction: Within the context of the coronavirus disease 2019 (COVID-19) pandemic, this study investigated the multifaceted challenges of bacterial infections in cancer patients with COVID-19. It focuses on clinical predictors,...
3.
Eissa M, Sabry R, Abdellateif M
Exp Clin Endocrinol Diabetes
. 2024 Aug;
132(11):596-606.
PMID: 39102864
Objective: To evaluate the accuracy of thyroid imaging reporting and data system (ACR-TIRADS) and the Bethesda system for reporting cytopathology (TBSRCP) classifications for identifying or ruling out thyroid malignancy in...
4.
Abdellateif M, Hassan N, Kamel M, El-Meligui Y
Oncol Res
. 2024 Feb;
32(3):577-584.
PMID: 38361758
Background: microRNA-34a (miR-34a) had been reported to have a diagnostic role in acute myeloid leukemia (AML). However, its value in the bone marrow (BM) of AML patients, in addition to...
5.
Abdellateif M, Zekri A
J Egypt Natl Canc Inst
. 2023 Nov;
35(1):35.
PMID: 37926787
Hepatocellular carcinoma (HCC) is a major health problem worldwide, especially for patients who are suffering from end-stage liver disease (ESLD). The ESLD is considered a great challenge for clinicians due...
6.
Abdellateif M, Bayoumi A, Mohammed M
Onco Targets Ther
. 2023 Oct;
16:785-799.
PMID: 37790582
c-Kit is a type III receptor tyrosine kinase (RTK) that has an essential role in various biological functions including gametogenesis, melanogenesis, hematopoiesis, cell survival, and apoptosis. c-KIT aberrations, either overexpression...
7.
Kotb R, Afifi A, El-Houseini M, Ezz-Elarab M, Basalious E, Omran M, et al.
Discov Oncol
. 2023 Sep;
14(1):169.
PMID: 37704828
Background: This is a phase II clinical trial to investigate the immunotherapeutic effect of Curcumin, Piperine, and Taurine (CPT) combination in hepatocellular carcinoma (HCC). Methods: Twenty-six HCC patients aged (50-80...
8.
El-Houseini M, Arafat M, El-Husseiny A, Kasem I, Kamel M, El-Habashy A, et al.
Oncol Res
. 2023 Jun;
29(5):319-330.
PMID: 37305162
Methods: The study was designed to optimize the condition for producing an effective dendritic cell (DCs) based immunotherapy by using DCs and T lymphocytes together with tumor-infiltrating lymphocytes (TILs) and...
9.
El Ashry M, Radwan E, Abdellateif M, Arafah O, Hassan N
J Egypt Natl Canc Inst
. 2023 Jun;
35(1):17.
PMID: 37303010
Background: T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive malignancy with few accepted prognostic factors that limit the efficiency of therapy. The aim of the current study was to assess...
10.
Nabil R, Abdellateif M, Gamal H, Hassan N, Badawy R, Ghareeb M, et al.
Leuk Res
. 2023 Jan;
126:107019.
PMID: 36657369
Background: Acute leukemia is a common health problem in adults and children, however its exact molecular etiology is still unclear. Methods: The expression of EVI-1 was assessed in the bone...